Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

3-(4-methylpiperazin-1-yl)-5-(3-nitrobenzylamino)-7-(trifluoromethyl)quinoline MeSH Supplementary Concept Data 2025


MeSH Supplementary
3-(4-methylpiperazin-1-yl)-5-(3-nitrobenzylamino)-7-(trifluoromethyl)quinoline
Unique ID
C000590925
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000590925
Entry Term(s)
SOMG-833
Registry Numbers
0
Heading Mapped to
*Aminoquinolines
*Piperazines
Frequency
1
Note
a c-Met kinase inhibitor with antineoplastic activity; structure in first source
Source
J Pharmacol Exp Ther. 2014 Jul;350(1):36-45.
Date of Entry
2014/08/21
Revision Date
2014/08/21
3-(4-methylpiperazin-1-yl)-5-(3-nitrobenzylamino)-7-(trifluoromethyl)quinoline Preferred
SOMG-833 Narrower
page delivered in 0.005s